✦ LIBER ✦

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

✍ Scribed by van Genugten, R. E.; Möller-Goede, D. L.; van Raalte, D. H.; Diamant, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incretin-Based Therapies for the Treatme

✍ Drucker, D. J.; Sherman, S. I.; Gorelick, F. S.; Bergenstal, R. M.; Sherwin, R. 📂 Article 📅 2010 🏛 American Diabetes Association 🌐 English ⚖ 231 KB

Glucagonlike Peptide 1–Based Therapies a

✍ Singh, Sonal; Chang, Hsien-Yen; Richards, Thomas M.; Weiner, Jonathan P.; Clark, 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 158 KB

Incretin therapies and risk of hospital

✍ Giorda, Carlo B; Picariello, Roberta; Nada, Elisa; Tartaglino, Barbara; Marafett 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 229 KB

Effectiveness of a hospital-based vascul

✍ B. G. Brouwer; F. L. J. Visseren; A. Algra; J. H. Van Bockel; E. L. E. M. Bollen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB